Active Surveillance with Color-Doppler Ultrasound Monitoring: Is it Foolproof? | Duke Bahn, MD, Mark Scholz, MD, Richard Lam, MD | 2007
Active Surveillance For Favorable Risk Prostate Cancer: What Are The Results and How Safe Is It? | Laurence Klotz, MD | 2013
Active Surveillance: Q&A with Laurence Klotz, MD | Lawrence Klotz, MD | 2013
Patient Mark Lichty describes his active surveillance experience.
Patient Jim Goodacre describes his prostate biopsy experiences.
Bela Denes, MD, discusses his experiences with TRUS "blind" biopsies. He is Senior Director of Director of Urology at Genomic Health, Inc.
Robert Princenthal, MD, discusses the advantages of a targeted biopsy of a random needle biopsy. He is President of Rolling Oaks Radiology in California.
Robert Princenthal, MD discusses MRI improvements over TRUS biopsy. He is President of Rolling Oaks Radiology in California.
Ferd Becker, MD, discussed getting an MRI before a biopsy. He is a physician and an active surveillance patient.
Patient Lyle LaRosh discusses a targeted biopsy over random needle biopsy. He is President of the Informed Prostate Cancer Support Group in San Diego.
Patient Carlos Orillo discusses surviving a serious bout with sepsis.
Mark Scholz, MD discusses the criteria for Active Surveillance. He is Medical Director of Prostate Oncology Specialists Inc. in Marina Del Rey, California.
Patient Jim Bertoni describes how he adapted to an active surveillance regimen
Patient Jerry Mayo followed an active surveillance regimen for over 13 years.
Patient Dave Perez lives in California and has followed an active surveillance regimen for over 5 years.
Patient Mark Lichty chairs an annual meeting of approximately 50 active surveillance patients.
Charles “Snuffy” Myers, MD, is a medical oncologist and prostate cancer patient.
Robert Princenthal, MD, is President of Rolling Oaks Radiology in California.
Ferd Becker, MD, is a board-certified facial plastic surgeon and he is also an active surveillance patient.
Patient Jim Bertoni resides in California and is a member of the Prostate Forum of Orange County.
What treatment complications did your friends experience?
Patient Franisco Jiminez was diagnosed at age 61 with a Gleason 6.
Terry Sommerhauer began doing research once her husband was diagnosed with prostate cancer.
Patient Ferd Becker, MD, has been an active surveillance patient for 4 years.
Patient Gene Van Vleet is COO of the Informed Prostate Cancer Support Group in San Diego.
Ferd Becker, MD, is an active surveillance patient and a board-certified facial plastic surgeon.
Patient Paul Potash lives in San Diego and has followed an active surveillance regimen for 2 ½ years.
Patient Bill Manning started active surveillance in 2009.
Patient Dave Perez followed many paths to suppress his PCa.
Patient Jerry Mayo followed an active surveillance regimen for over 13 years before seeking treatment.
Patient Mark Lichty has followed a raw food diet and his PSA has remained stable over 10 years.
Patient Paul Potash lives in La Jolla, California and has followed active surveillance since 2005.
Robert Princenthal, MD, is President of Rolling Hills Radiology in California.
Patient Gene Van Vleet is COO of the Informed Prostate Cancer Support Group, San Diego, CA.
Patient Bill Manning discusses how a larger gland size allows for a higher but normal PSA.
Gene Van Vleet is Chief Operating Officer of the Informed Prostate Cancer Support Group in San Diego.
Patient Jim Bertoni is a member of the Prostate Forum of Orange County, California.
Bela Denes, MD, is the Senior Director of Urology with the Genomic Health Medical Affairs Team.
Karen Kunz, BSN, C.U.R.N, is a certified urology nurse at Myriad Genetics.
Our thanks to those who helped in special ways with the development of these active surveillance interviews. Mark Scholz, MD, Medical Director of Prostate Oncology Specialists, made this project possible. Silvia Cooper, Chief Administrative Officer of PCRI, provided editorial suggestions and helped facilitate this project. Jan Manarite brought her knowledge of patient needs from years of experience as an educational facilitator on the PCRI helpline. Prostate cancer patient Dave Middleton shared his many years as an Us-TOO chapter facilitator in California. Bill Manning, an active surveillance patient, photographed interviews in the San Diego area. Won-ji Seo edited these video interviews. A special thanks to the patients, significant others and medical experts who shared their perspectives. These interviews were guided and produced by Bob Aller, who has made award-winning documentaries on healthcare subjects including autism, adverse medication reactions, scientific methodology, and prostate cancer. Bob believes that patients sharing their experience and insights make an invaluable contribution to patient education. Our team hopes that the active surveillance video content presented here can benefit many men and their significant others.